Explore All 789 Divestiture Life Science Deals - Search the Database Free
M&A Deal Summary |
|
|---|---|
| Date | February 28, 2005 |
| Target | JRH Biosciences |
| Sector | Life Science |
| Buyer(s) | Sigma-Aldrich |
| Sellers(s) | CSL |
| Deal Type | Divestiture |
| Deal Value | 370M USD |
FILTER BY
| Category | Company |
|---|---|
| Founded | 1951 |
| Sector | Life Science |
| Employees | 9,800 |
| Revenue | 2.8B USD (2014) |
Sigma-Aldrich Corp. is a life science and high technology company whose biochemical, organic chemical products, kits, and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university, and government institutions, hospitals, and industry.
| Deal Context for Buyer | # |
|---|---|
| Overall | 3 of 13 |
| Sector: Life Science | 3 of 10 |
| Type: Divestiture | 1 of 3 |
| Country: United States | 2 of 9 |
| Year: 2005 | 1 of 1 |
| Size (of disclosed) | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2004-06-22 |
Tetrionics
Madison, Wisconsin, United States Tetrionics supplies pharmaceutical development market with high purity vitamin D analogs. Its services include synthesis and scale up, analytical chemistry, regulatory support and current good manufacturing practice (cGMP) of active pharmaceutical ingredients across a broad range of structural classes of molecules with a strong emphasis on high potency and cytotoxic compounds. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2006-05-03 |
Iropharm
Dublin, Delaware, Ireland Iropharm, which operates a U.S. Food and Drug Administration-inspected manufacturing facility in Arklow near Dublin, is a producer of high-quality fine chemicals for the pharmaceutical industry. The company makes both intermediate and active ingredients under current Good Manufacturing Practices (cGMP). |
Buy | - |
| Category | Company |
|---|---|
| Founded | 1916 |
| Sector | Life Science |
| Employees | 29,904 |
| Revenue | 15.4B AUD (2025) |
CSL is a manufacturer and marketer of pharmaceutical and diagnostic products, cell culture media and human plasma fractions. CSL was founded in 1916 and is based in Melbourne, Australia.
| Deal Context for Seller | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Life Science | 1 of 2 |
| Type: Divestiture | 1 of 2 |
| Country: United States | 1 of 2 |
| Year: 2005 | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2008-08-12 |
Talecris Biotherapeutics Holdings Corp
Research Triangle Park, North Carolina, United States Talecris Biotherapeutics Holdings Corp. is a pharmaceutical Development and Manufacturing company. |
Buy | $3.1B |
